John J. Orloff, EVP, Research & Development at ALEXION PHARMACEUTICALS INC (ALXN), sold 4,230 shares at $118.53 ($501K) on 2018-06-08, disclosed to the SEC on 2018-06-12.
Open-market sale of $501k ALXN by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.53 | 2,115 | $251K | 50.0% |
| 2 | $118.53 | 2,115 | $251K | 50.0% |
| Total | $118.53 avg | 4,230 | $501K | 100% |